Dang, C. V. MYC on the path to cancer. Cell 149, 22–35 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhanasekaran, R. et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19, 23–36 (2022). This review provides a helpful overview on the role of MYC as cancer driver and immune modulator.

Article  CAS  PubMed  Google Scholar 

Llombart, V. & Mansour, M. R. Therapeutic targeting of “undruggable” MYC. EBioMedicine 75, 103756 (2022). This review gives an important overview of MYC as a therapeutic target, including indirect approaches.

Article  CAS  PubMed  Google Scholar 

Dang, C. V., Reddy, E. P., Shokat, K. M. & Soucek, L. Drugging the ‘undruggable’ cancer targets. Nat. Rev. Cancer 17, 502–508 (2017). This review illustrates the historical difficulties associated with targeting some of the key players in cancer development and maintenance.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whitfield, J. R., Beaulieu, M. E. & Soucek, L. Strategies to inhibit myc and their clinical applicability. Front. Cell Dev. Biol. 5, 10 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Soucek, L. et al. Modelling Myc inhibition as a cancer therapy. Nature 455, 679–683 (2008). This is a key study that demonstrates how systemic MYC inhibition in mice was not only efficacious against tumour growth but also had minimal side effects in normal proliferating tissues.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garralda, E. et al. MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nat. Med. 30, 762–771 (2024). This article reports the first successful clinical trial of a direct MYC inhibitor, including first hints of efficacy and potential biomarkers.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karadkhelkar, N. M., Lin, M., Eubanks, L. M. & Janda, K. D. Demystifying the druggability of the MYC family of oncogenes. J. Am. Chem. Soc. 145, 3259–3269 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whitfield, J. R. & Soucek, L. The long journey to bring a Myc inhibitor to the clinic. J. Cell Biol. 220, e202103090 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duesberg, P. H. & Vogt, P. K. Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes. Proc. Natl Acad. Sci. USA 76, 1633–1637 (1979).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sheiness, D. & Bishop, J. M. DNA and RNA from uninfected vertebrate cells contain nucleotide sequences related to the putative transforming gene of avian myelocytomatosis virus. J. Virol. 31, 514–521 (1979).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beaulieu, M. E. et al. Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy. Sci. Transl. Med. 11, eaar5012 (2019). This article reports the discovery of how the intrinsic cell-penetrating properties of Omomyc converted a proof-of-concept genetic MYC inhibitor into a viable clinical option.

Article  PubMed  PubMed Central  Google Scholar 

Berg, T. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl Acad. Sci. USA 99, 3830–3835 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blackwood, E. M. & Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251, 1211–1217 (1991).

Article  CAS  PubMed  Google Scholar 

Duesberg, P. H. & Vogt, P. K. Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses. Proc. Natl Acad. Sci. USA 67, 1673–1680 (1970).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin, G. S. Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature 227, 1021–1023 (1970).

Article  CAS  PubMed  Google Scholar 

Nair, S. K. & Burley, S. K. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112, 193–205 (2003).

Article  CAS  PubMed  Google Scholar 

Prochownik, E. V., Kukowska, J. & Rodgers, C. c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol. Cell Biol. 8, 3683–3695 (1988).

CAS  PubMed  PubMed Central  Google Scholar 

Senapedis, W. et al. Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models. Nat. Commun. 15, 7875 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soucek, L. et al. Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene 17, 2463–2472 (1998).

Article  CAS  PubMed  Google Scholar 

Soucek, L. et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev. 27, 504–513 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–173 (1976).

Article  CAS  PubMed  Google Scholar 

Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

Article  CAS  PubMed  Google Scholar 

Vennstrom, B., Sheiness, D., Zabielski, J. & Bishop, J. M. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J. Virol. 42, 773–779 (1982).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zimmerman, K. A. et al. Differential expression of myc family genes during murine development. Nature 319, 780–783 (1986).

Article  CAS  PubMed  Google Scholar 

Masso-Valles, D., Beaulieu, M. E. & Soucek, L. MYC, MYCL, and MYCN as therapeutic targets in lung cancer. Expert Opin. Ther. Targets 24, 101–114 (2020).

Article  CAS  PubMed  Google Scholar 

Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976–990 (2008).

Article  CAS  PubMed  Google Scholar 

Conacci-Sorrell, M., McFerrin, L. & Eisenman, R. N. An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 4, a014357 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Beaulieu, M. E., Castillo, F. & Soucek, L. Structural and biophysical insights into the function of the intrinsically disordered myc oncoprotein. Cells 9, 1038 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao, D. Y. et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13, 882–886 (2003).

Article